Moreover, the Hb/RDW ratio demonstrates its predictive capabilities post-treatment, as observed in gastric cancer patients treated with neo-adjuvant fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) [32]. This evidence concerns the gene GSTM1 and gastric cancer.